Top Stocks
Dividend Investing
ETFs
Stock Comparison
About Us
Working with TipRanks
Follow Us
Canaan IX L.P. Insider Profile
4 Followers
Canaan IX L.P., Director, Ten Percent Owner at CytomX Therapeutics, holds 3.59M shares in Arvinas Holding Company (Ticker: ARVN), holds 7.93M shares in RealReal (Ticker: REAL), holds 4.58M shares in CytomX Therapeutics (Ticker: CTMX).
Canaan IX L.P. CytomX Therapeutics (CTMX)Director, Ten Percent Owner
CytomX Therapeutics (CTMX)
Director, Ten Percent Owner
Ranked #101,529 out of 103,103 Corporate Insiders
Profitable Transactions
0 out of 14 Profitable Transactions
Average Return
-54.50%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Canaan IX L.P. holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Sell
Date:Jun 10, 2016 - Jun 10, 2017
Return:-30.10%
The most profitable trade made by Canaan IX L.P.
Canaan IX L.P.'s Trading History
CytomX Therapeutics
Mar 28, 2017
Director, Ten Percent Owner
Uninformative Sell
―
$7.02M
Arvinas Holding Company
Oct 15, 2020
Ten Percent Owner
Uninformative Sell
―
$100.04M
RealReal
Jan 16, 2020
Ten Percent Owner
Uninformative Sell
―
$9.27M
List of latest transactions for each holding click on a transaction to see Canaan IX L.P.'s performance on stock
You May Also Like
Canaan IX L.P. insider profile FAQ
What is the percentage of profitable transactions made by Canaan IX L.P.?
The percentage of profitable transactions made by Canaan IX L.P. is 0%.
What is the average return per transaction made by Canaan IX L.P.?
The average return per transaction made by Canaan IX L.P. is -54.50%.
What stocks does Canaan IX L.P. hold?
Canaan IX L.P. holds: CTMX, ARVN, REAL stocks.
What was Canaan IX L.P.’s latest transaction?
Canaan IX L.P. latest transaction was an Uninformative Sell of ―.
What was Canaan IX L.P.'s most profitable transaction?
Canaan IX L.P.’s most profitable transaction was an Informative Sell of CTMX stock on June 10, 2016. The return on the trade was -30.10%.
What is Canaan IX L.P.'s role in CytomX Therapeutics?
Canaan IX L.P.'s role in CytomX Therapeutics is Director, Ten Percent Owner.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.